Eisai (OTCMKTS:ESALY) Coverage Initiated by Analysts at Sanford C. Bernstein

Sanford C. Bernstein initiated coverage on shares of Eisai (OTCMKTS:ESALYGet Rating) in a report released on Tuesday morning, The Fly reports. The firm issued an outperform rating on the stock.

Eisai Price Performance

Shares of ESALY opened at $61.51 on Tuesday. The company has a market cap of $17.64 billion, a price-to-earnings ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31. Eisai has a twelve month low of $36.88 and a twelve month high of $73.90. The company has a quick ratio of 1.77, a current ratio of 2.20 and a debt-to-equity ratio of 0.10. The company has a 50 day moving average of $61.51 and a two-hundred day moving average of $63.24.

About Eisai

(Get Rating)

Eisai Co, Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs.

Further Reading

The Fly logo

Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.